Our Aspirations
ALIGN STAKEHOLDERS
MOBILIZE COMMUNITIES
BUILD AWARENESS
Bioelectronic medicine is making rapid strides, but this is just the beginning of what's possible. If supported by robust investment, appropriate health policy, regulation, and reimbursement, and widespread physician and patient adoption, this field could address some of the greatest challenges in healthcare.
To realize the field's full potential, bioelectronic medicine stakeholders - including companies, research institutes, universities, investors, and forward-thinking medical practitioners - will need to work together to build awareness and support.
In particular, we must clearly articulate how bioelectronic medicine stands to benefit people, and to use that as a foundation for driving a powerful movement that reaches patients, providers, policymakers and regulators, payers, and others. By taking specific actions to advance the field, as outlined in our white paper, diverse stakeholders can help to build a true bioelectronic medicine movement.
Ultimately, this engagement and support will be just as important for bioelectronic medicine's future as scientific and technical progress.
Steering Committee
Dr. Samuel Asirvatham
Vice Chair, Innovation and Medical Director, Electrophysiology Laboratory, Mayo Clinic
DR. THOMAS DEERING
Chief of the Arrhythmia Center, Piedmont Heart Institute; Immediate Past President, Heart Rhythm Society
DR. HEIN HEIDBUCHEL
Professor and Chair of Cardiology Antwerp University; President, European Heart Rhythm Association
DR. SURAJ KAPA
Director, Augmented and Virtual Reality Innovation, Mayo Clinic
Dr. BARRY KEENAN
CEO, Nervonik, Inc.
MR. KEN LONDONER
Founder, CEO, and Chairman BioSig Technologies, Inc.
DR. ELAD MAOR
Interventional Cardiologist, Sheba Medical Center
DR. SOEREN MATTKE
Director, Center for Improving Chronic Illness Care, University of Southern California
DR. LEFKOS T MIDDLETON
Professor of Neurology, Ageing Research, School of Public Health, Imperial College London and Honorary Consultant, Imperial College NHS Healthcare Trust
DR. VALENTIN PAVLOV
Professor, Center for Biomedical Science and Bioelectronic Medicine, The Feinstein Institute for Medical Research; Executive Editor, Bioelectronic Medicine
DR. DOUGLAS WEBER
Associate Professor of Bioengineering, University of Pittsburgh, Director of Neurotechnology R&D, Battelle
AABM Secretariat
High Lantern Group serves as the secretariat for the Alliance for Advancing Bioelectronic Medicine. For more information, please contact info@advancingbioelectronicmedicine.org.
ms. Chardon Brooks
Communications Associate, BioSig Technologies, Inc.
MS. KELLY JACKSON
Associate, High Lantern Group
MR. CHARLES PENNELL
Director, High Lantern Group